Skip to main content
. 2016 Oct 24;4:89. Originally published 2015 Apr 9. [Version 2] doi: 10.12688/f1000research.6241.2

Table 4. Increased abundance of ADAM9 following tissue injury and sterile inflammation.

GEO ID A vs B Avg A-Avg B Avg A/Avg B P value
GSE34608 Sarcoidosis VS Control 56.4 1.9 < 0.0001
Tuberculosis VS control 56.9 1.9 < 0.0001
GSE11375 Survived VS Control 17.7 1.2 0.0367
Died VS Control 45.2 1.6 0.0226
Survived VS Died 27.5 1.3 0.0473
GSE15072 HD VS Healthy 545.6 7.6 < 0.0001
CKD VS Healthy 94.3 2.1 0.0359
GSE28750 Post surgery VS Healthy 153.2 5.1 < 0.0001
Sepsis VS Healthy 281.8 8.5 < 0.0001
GSE30174 ** Healthy VS Baseline 35.8 1.1 0.7243
Healthy VS 1h EBRT -91.3 0.9 0.4727
Healthy VS D7 EBRT 236.5 1.4 0.1419
Healthy VS D14 EBRT 455.8 1.7 0.0068
Healthy VS D21 EBRT 643.8 2.0 0.0021
Healthy VS D42 EBRT 272.1 1.4 0.2150
Healthy VS 1 mo Post Tx 85.8 1.1 0.5678
GSE32575 Obese before surgery VS control 34.1 1.3 < 0.0001
Obese post surgery VS control 19.0 1.2 0.0001
GSE5580 TP mono VS HC mono 247.1 1.7 0.0070
TP Leukocyte VS HC Leukocyte 233.2 2.9 0.0006
TP T cell VS HC T cell 57.9 3.0 0.0175

Note : Avg = average abundance of ADAM9 within a given group. Statistical significance was determined using Mann-Whitney U test. ** This dataset was tested by One-way ANOVA and Dunnett’s multiple comparisons test, P value summary = 0.0042.